Literature DB >> 20412114

Hereditary hemorrhagic telangiectasia: two distinct ENG deletions in one family.

W Wooderchak1, F Gedge, M McDonald, P Krautscheid, X Wang, J Malkiewicz, C J Bukjiok, T Lewis, P Bayrak-Toydemir.   

Abstract

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterized by aberrant vascular development. Mutations in endoglin (ENG) or activin A receptor type II-like 1 (ACVRL1) account for around 90% of HHT patients, 10% of those are large deletions or duplications. We report here the first observation of two distinct, large ENG deletions segregating in one pedigree. An ENG exon 4-7 deletion was observed in a patient with HHT. This deletion was identified in several affected family members. However, some affected family members had an ENG exon 3 deletion instead. These deletions were detected by multiplex ligation-dependent probe amplification and confirmed by mRNA sequencing and an oligo-CGH array. Linkage analysis revealed that one individual with the exon 3 deletion inherited the same chromosome from his mother who has the exon 4-7 deletion. This finding has important clinical implications because it shows that targeted family-specific mutation analysis for exon deletions could have led to the misdiagnosis of some affected family members.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20412114     DOI: 10.1111/j.1399-0004.2010.01418.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  5 in total

1.  Hereditary Hemorrhagic Telangiectasia: Breakpoint Characterization of a Novel Large Deletion in ACVRL1 Suggests the Causing Mechanism.

Authors:  Laura Boeri; Orietta Radi; Cecilia Canzonieri; Elisabetta Buscarini; Agnese Scatigno; Antonella Minelli; Federica Ornati; Fabio Pagella; Cesare Danesino; Carla Olivieri
Journal:  Mol Syndromol       Date:  2013-02-28

Review 2.  Standard anticoagulation for mesenteric vein thrombosis, revealing a 'zebra' diagnosis: hereditary haemorrhagic telangiectasia--the dripping truth!

Authors:  Aakash Aggarwal; Arundeep Singh Kahlon; Meghan Rane; Emerald Banas
Journal:  BMJ Case Rep       Date:  2013-10-28

3.  Novel 9q34.11 gene deletions encompassing combinations of four Mendelian disease genes: STXBP1, SPTAN1, ENG, and TOR1A.

Authors:  Ian M Campbell; Svetlana A Yatsenko; Patricia Hixson; Tyler Reimschisel; Matthew Thomas; William Wilson; Usha Dayal; James W Wheless; Amy Crunk; Cynthia Curry; Nicole Parkinson; Leona Fishman; James J Riviello; Malgorzata J M Nowaczyk; Susan Zeesman; Jill A Rosenfeld; Bassem A Bejjani; Lisa G Shaffer; Sau Wai Cheung; James R Lupski; Pawel Stankiewicz; Fernando Scaglia
Journal:  Genet Med       Date:  2012-06-21       Impact factor: 8.822

Review 4.  Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era.

Authors:  Jamie McDonald; Whitney Wooderchak-Donahue; Chad VanSant Webb; Kevin Whitehead; David A Stevenson; Pinar Bayrak-Toydemir
Journal:  Front Genet       Date:  2015-01-26       Impact factor: 4.599

5.  Copy number variations in endoglin locus: mapping of large deletions in Spanish families with hereditary hemorrhagic telangiectasia type 1.

Authors:  Ana Fontalba; Jose L Fernández-Luna; Roberto Zarrabeitia; Lucia Recio-Poveda; Virginia Albiñana; Maria L Ojeda-Fernández; Carmelo Bernabéu; Luis A Alcaraz; Luisa M Botella
Journal:  BMC Med Genet       Date:  2013-11-25       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.